Eton Pharmaceuticals (ETON) Gains from Investment Securities (2018)
Eton Pharmaceuticals' (ETON) quarterly Gains from Investment Securities came in at $1.5 million in Q4 2018, up 172.01% quarter-over-quarter from $561000.0 in Q3 2018.
Powered by 
Analysis
Eton Pharmaceuticals (ETON) Gains from Investment Securities (2018) Analysis & Trends
Eton Pharmaceuticals has disclosed Gains from Investment Securities across 1 years of filings, most recently posting $1.5 million for Q4 2018.
- In Q4 2018, Gains from Investment Securities changed N/A year-over-year to $1.5 million; the TTM figure through Dec 2018 stood at $2.6 million (changed N/A YoY), while the FY2020 annual figure was $226000.0, changed 0.0% from the prior year.
- Gains from Investment Securities came in at $1.5 million for Q4 2018 at Eton Pharmaceuticals, up from $561000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.5 million in Q4 2018 to a low of $83000.0 in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Eton Pharmaceuticals | 1.63 Bn | 1.60 Bn | 25.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 1.53 Mn |
| Sep 30, 2018 | 561,000.00 |
| Jun 30, 2018 | 413,000.00 |
| Mar 31, 2018 | 83,000.00 |